Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Clinical trial NCT02098538 · COMPLETED
Trial details
- NCT number
- NCT02098538
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2024-11-07
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.